Email
Print
Monoclonal Antibodies Market - Forecast(2024 - 2030)
Monoclonal Antibodies Market Overview:
According to Cancer Research UK, around 17 million new cases of cancer and 9.6 million mortality incidences were recorded globally in 2018. [1] As per this statistic, the cancer threat is increasing rapidly throughout the world and safer medical treatment is being sought out over more conventional methods. Antibody vaccines effectively induce the desired medication with comparatively higher rates of success, leading to the development of monoclonal antibodies (mAbs), which target a specific area or cell. Designed in laboratories with an aim to trigger the natural immune system and destroy cancer-causing cells, monoclonal antibodies are a flagship innovation in the medical sector approved by the U.S. Food and Drug Administration (FDA) as an effective measure for cancer treatment. Potential benefits of monoclonal antibodies include detecting and killing abnormal cells directly, inhibiting cancer cell growth, and delivering radioactive particles or chemo drugs to the specific cells, thereby minimizing the risk of side effects from medication while also promoting functioning of the immune system.
Proven to be effective in the treatment of brain cancer, lung cancer, prostate cancer, breast cancer, and many other types, mAb therapy is attracting huge demand. Not only are mAbs being used to treat cancer, but its therapeutic use in treating ulcerative colitis, rheumatoid arthritis, asthma, Crohn’s disease, and ankylosing spondylitis is also notable. The global monoclonal antibodies market stood at $101.5 billion in 2018 owing to increasing adoption of mAbs throughout the world. Due to the ever-increasing population and incidences of cancer, the mAbs market is expected to grow at a CAGR of 8.51% through to 2025.
Monoclonal Antibodies Market Outlook:
The advent of monoclonal antibodies hybridoma technology, and production of mAbs in large quantities in accordance with targeted antigens of defective cells opened up wider avenues for biochemistry, molecular biology, and medicine. Mounting demand influenced by growing medico-technological advancements will contribute to the European mAbs market. Currently, Europe is the fastest-growing mAbs market owing to colossal expenditure in biomedical engineering brought about by increasing health risks, which culminated in the region holding a market share of 42.30% in 2018. Administered intravenously, mAb vaccinations are sought after across the world because they cause no adverse effects on the peripheral area, which was proved through successful experimental trials. Monoclonal antibodies market is majorly fueled by the oncology segment, projected to increase at a CAGR of 8.67% and expand with lucrative revenue in the foreseeable years.
Monoclonal Antibodies Market Growth Drivers:
· Increasing incidences of cancer, autoimmune diseases, infectious diseases, inflammatory diseases, and microbial diseases have a contributory role in generating huge demand for mAb therapy.
· Homogeneity of mAbs makes them suitable for experimental procedures also since they can facilitate production of identical antibodies. Thus, they are able to keep up with the increasing requirements of the healthcare industry.
· Unlimited production and specific clone identification with respect to a particular antigen make it a unique product engineered with ease in laboratories.
Monoclonal Antibodies Market Challenges:
Certain issues that arise during manufacturing of mAbs include the cost-inefficient procedure and susceptibility towards contamination during the hybridoma culture. Furthermore, production requires additional cell culture and purification procedures for successfully yielding mAbs. Key companies in the sector are attempting to overcome these challenges by conducting extensive research.
Monoclonal Antibodies Market Key Players:
The major companies leading the global monoclonal antibodies market include Johnson & Johnson Services, Inc., Amgen Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., Thermo Fisher Scientific, Daiichi Sankyo Company, Ltd., Bayer AG, Merck & Co., Inc, Biogen Inc., Sanofi Genzyme, GlaxoSmithKline plc, Novo Nordisk A/S, Bristol Myers Squibb Co., and others.
GlaxoSmithKline plc is a multinational pharmaceutical company manufacturing vaccines and healthcare products. One of their major achievements in 2018 involves vending 770 million doses of vaccines.
Monoclonal Antibodies Market Trends:
- Metastatic
Cancer Treatment:
The second highest cause of death, cancer has been around for more than a thousand years. Dating back to the ancient Greek civilization, cancer trauma has compelled important discoveries and scientific innovations globally. One of the major breakthroughs is the introduction of mAbs for treating advanced and metastatic cancers. Earlier, metastatic tumors had no actual treatment procedures but therapeutic approaches of mAbs have accomplished significant results in modern times.
Monoclonal Antibodies Market Research Scope:
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the monoclonal antibodies market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of monoclonal antibodies in monoclonal antibodies market, and their specific applications in different areas.
Monoclonal Antibodies Market: Industry Coverage:
Global monoclonal antibodies market has only one segmentation which is application. Categorization based on application includes oncology, autoimmune and inflammatory diseases, respiratory diseases and ophthalmology.
The monoclonal antibodies market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
- North America: The U.S., Canada, Mexico
- South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
- Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
- APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
- Middle East and Africa: Israel, South Africa, Saudi Arabia
For more Lifesciences and Healthcare related reports,
please click here
Table 1: Monoclonal Antibodies Market Overview 2023-2030
Table 2: Monoclonal Antibodies Market Leader Analysis 2023-2030 (US$)
Table 3: Monoclonal Antibodies Market Product Analysis 2023-2030 (US$)
Table 4: Monoclonal Antibodies Market End User Analysis 2023-2030 (US$)
Table 5: Monoclonal Antibodies Market Patent Analysis 2013-2023* (US$)
Table 6: Monoclonal Antibodies Market Financial Analysis 2023-2030 (US$)
Table 7: Monoclonal Antibodies Market Driver Analysis 2023-2030 (US$)
Table 8: Monoclonal Antibodies Market Challenges Analysis 2023-2030 (US$)
Table 9: Monoclonal Antibodies Market Constraint Analysis 2023-2030 (US$)
Table 10: Monoclonal Antibodies Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Monoclonal Antibodies Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Monoclonal Antibodies Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Monoclonal Antibodies Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Monoclonal Antibodies Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Monoclonal Antibodies Market Value Chain Analysis 2023-2030 (US$)
Table 16: Monoclonal Antibodies Market Pricing Analysis 2023-2030 (US$)
Table 17: Monoclonal Antibodies Market Opportunities Analysis 2023-2030 (US$)
Table 18: Monoclonal Antibodies Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Monoclonal Antibodies Market Supplier Analysis 2023-2030 (US$)
Table 20: Monoclonal Antibodies Market Distributor Analysis 2023-2030 (US$)
Table 21: Monoclonal Antibodies Market Trend Analysis 2023-2030 (US$)
Table 22: Monoclonal Antibodies Market Size 2023 (US$)
Table 23: Monoclonal Antibodies Market Forecast Analysis 2023-2030 (US$)
Table 24: Monoclonal Antibodies Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 26: Monoclonal Antibodies Market By Application, Revenue & Volume, By Oncology, 2023-2030 ($)
Table 27: Monoclonal Antibodies Market By Application, Revenue & Volume, By Autoimmune and inflammatory diseases, 2023-2030 ($)
Table 28: Monoclonal Antibodies Market By Application, Revenue & Volume, By Respiratory diseases, 2023-2030 ($)
Table 29: Monoclonal Antibodies Market By Application, Revenue & Volume, By Ophthalmology UV-Visible (Photodiode Array, Handheld), 2023-2030 ($)
Table 30: North America Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 31: South america Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 32: Europe Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 33: APAC Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 34: Middle East & Africa Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 35: Russia Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 36: Israel Monoclonal Antibodies Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 37: Top Companies 2023 (US$)Monoclonal Antibodies Market, Revenue & Volume
Table 38: Product Launch 2023-2030Monoclonal Antibodies Market, Revenue & Volume
Table 39: Mergers & Acquistions 2023-2030Monoclonal Antibodies Market, Revenue & Volume
List of Figures
Figure 1: Overview of Monoclonal Antibodies Market 2023-2030
Figure 2: Market Share Analysis for Monoclonal Antibodies Market 2023 (US$)
Figure 3: Product Comparison in Monoclonal Antibodies Market 2023-2030 (US$)
Figure 4: End User Profile for Monoclonal Antibodies Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Monoclonal Antibodies Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Monoclonal Antibodies Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Monoclonal Antibodies Market 2023-2030
Figure 8: Ecosystem Analysis in Monoclonal Antibodies Market 2023
Figure 9: Average Selling Price in Monoclonal Antibodies Market 2023-2030
Figure 10: Top Opportunites in Monoclonal Antibodies Market 2023-2030
Figure 11: Market Life Cycle Analysis in Monoclonal Antibodies Market
Figure 12: Global By ApplicationMonoclonal Antibodies Market Revenue, 2023-2030 ($)
Figure 13: Global Monoclonal Antibodies Market - By Geography
Figure 14: Global Monoclonal Antibodies Market Value & Volume, By Geography, 2023-2030 ($)Â
Figure 15: Global Monoclonal Antibodies Market CAGR, By Geography, 2023-2030 (%)
Figure 16: North America Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 17: US Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 18: US GDP and Population, 2023-2030 ($)
Figure 19: US GDP - Composition of 2023, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2023-2030 ($)
Figure 21: Canada Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 22: Canada GDP and Population, 2023-2030 ($)
Figure 23: Canada GDP - Composition of 2023, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 25: Mexico Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 26: Mexico GDP and Population, 2023-2030 ($)
Figure 27: Mexico GDP - Composition of 2023, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 29: South America Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 30: Brazil Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil GDP and Population, 2023-2030 ($)
Figure 32: Brazil GDP - Composition of 2023, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 34: Venezuela Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 35: Venezuela GDP and Population, 2023-2030 ($)
Figure 36: Venezuela GDP - Composition of 2023, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 38: Argentina Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 39: Argentina GDP and Population, 2023-2030 ($)
Figure 40: Argentina GDP - Composition of 2023, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 42: Ecuador Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 43: Ecuador GDP and Population, 2023-2030 ($)
Figure 44: Ecuador GDP - Composition of 2023, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 46: Peru Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 47: Peru GDP and Population, 2023-2030 ($)
Figure 48: Peru GDP - Composition of 2023, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 50: Colombia Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 51: Colombia GDP and Population, 2023-2030 ($)
Figure 52: Colombia GDP - Composition of 2023, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 54: Costa Rica Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica GDP and Population, 2023-2030 ($)
Figure 56: Costa Rica GDP - Composition of 2023, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 58: Europe Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 59: U.K Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 60: U.K GDP and Population, 2023-2030 ($)
Figure 61: U.K GDP - Composition of 2023, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 63: Germany Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 64: Germany GDP and Population, 2023-2030 ($)
Figure 65: Germany GDP - Composition of 2023, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 67: Italy Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 68: Italy GDP and Population, 2023-2030 ($)
Figure 69: Italy GDP - Composition of 2023, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 71: France Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 72: France GDP and Population, 2023-2030 ($)
Figure 73: France GDP - Composition of 2023, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2023-2030 ($)
Figure 75: Netherlands Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 76: Netherlands GDP and Population, 2023-2030 ($)
Figure 77: Netherlands GDP - Composition of 2023, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 79: Belgium Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 80: Belgium GDP and Population, 2023-2030 ($)
Figure 81: Belgium GDP - Composition of 2023, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 83: Spain Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 84: Spain GDP and Population, 2023-2030 ($)
Figure 85: Spain GDP - Composition of 2023, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 87: Denmark Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 88: Denmark GDP and Population, 2023-2030 ($)
Figure 89: Denmark GDP - Composition of 2023, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 91: APAC Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 92: China Monoclonal Antibodies Market Value & Volume, 2023-2030
Figure 93: China GDP and Population, 2023-2030 ($)
Figure 94: China GDP - Composition of 2023, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2023-2030 ($)Monoclonal Antibodies Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 96: Australia Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 97: Australia GDP and Population, 2023-2030 ($)
Figure 98: Australia GDP - Composition of 2023, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 100: South Korea Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 101: South Korea GDP and Population, 2023-2030 ($)
Figure 102: South Korea GDP - Composition of 2023, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 104: India Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 105: India GDP and Population, 2023-2030 ($)
Figure 106: India GDP - Composition of 2023, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2023-2030 ($)
Figure 108: Taiwan Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 109: Taiwan GDP and Population, 2023-2030 ($)
Figure 110: Taiwan GDP - Composition of 2023, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 112: Malaysia Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 113: Malaysia GDP and Population, 2023-2030 ($)
Figure 114: Malaysia GDP - Composition of 2023, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 116: Hong Kong Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong GDP and Population, 2023-2030 ($)
Figure 118: Hong Kong GDP - Composition of 2023, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 120: Middle East & Africa Monoclonal Antibodies Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 121: Russia Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 122: Russia GDP and Population, 2023-2030 ($)
Figure 123: Russia GDP - Composition of 2023, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 125: Israel Monoclonal Antibodies Market Value & Volume, 2023-2030 ($)
Figure 126: Israel GDP and Population, 2023-2030 ($)
Figure 127: Israel GDP - Composition of 2023, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 129: Entropy Share, By Strategies, 2023-2030* (%)Monoclonal Antibodies Market
Figure 130: Developments, 2023-2030*Monoclonal Antibodies Market
Figure 131: Company 1 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 132: Company 1 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 133: Company 1 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 134: Company 2 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 135: Company 2 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136: Company 2 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 137: Company 3 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 138: Company 3 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139: Company 3 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 140: Company 4 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 141: Company 4 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142: Company 4 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 143: Company 5 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 144: Company 5 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145: Company 5 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 146: Company 6 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 147: Company 6 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148: Company 6 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 149: Company 7 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 150: Company 7 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151: Company 7 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 152: Company 8 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 153: Company 8 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154: Company 8 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 155: Company 9 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 156: Company 9 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157: Company 9 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 158: Company 10 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 159: Company 10 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160: Company 10 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 161: Company 11 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 162: Company 11 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163: Company 11 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 164: Company 12 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 165: Company 12 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166: Company 12 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 167: Company 13 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 168: Company 13 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169: Company 13 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 170: Company 14 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 171: Company 14 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172: Company 14 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)
Figure 173: Company 15 Monoclonal Antibodies Market Net Revenue, By Years, 2023-2030* ($)
Figure 174: Company 15 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175: Company 15 Monoclonal Antibodies Market Net Sales Share, By Geography, 2023 (%)